Onterris, Inc.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No SEC Form 4 filings for $ONT in the last 30 days.
See all $ONT insider activity →IP Group (LSE: IPO) sold 10 million shares in Oxford Nanopore, raising £21m. It retains a 7.23% stake valued at £151.5m. The sale enhances IP Group's financial flexibility while maintaining exposure to Oxford Nanopore's growth.
Oxford Nanopore Technologies' stock rose 7.3% to 214p, hitting a 52-week high of 218.4p. Deutsche Bank raised its price target to 210 GBp, and Panmure Liberum upgraded the stock to Buy. A court injunction against MGI Tech and insider share purchases also supported the rally. The FTSE 250 index advanced 0.9%, aiding the stock's performance.
AECOM won a contract from the Santa Clara Valley Water District to design a water reuse facility in California. The project will test direct potable reuse for future drinking water. Tetra Tech secured a $17M EPA contract, EA Engineering won broadband roles, and Worley landed BHP and Ontario energy storage work.
Over the past 7 days, AlphAI's AI scored 1 news story mentioning ONT (Onterris, Inc.). Coverage has been balanced: 0 bullish, 1 neutral, and 0 bearish.
Recent ONT coverage spans market movers, financial news and earnings.
The secondary sale may cause minor short‑term selling pressure but does not change fundamentals.
The price jump reflects market pricing of upgraded targets and a strengthened competitive position.
AECOM won a contract from the Santa Clara Valley Water District to design a water reuse facility in California. The project will test direct potable reuse for future drinking water. Tetra Tech secured a $17M EPA contract, EA Engineering won broadband roles, and Worley landed BHP and Ontario energy storage work.
Guidance reduction and anti‑takeover defense suggest near‑term downside pressure.
The large secondary sale pressured the stock, creating a short‑term sell signal.
AlphAI scores every news story that mentions ONT with an AI model for sentiment and relevance, and aggregates insider trades from Onterris, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
IP Group (LSE: IPO) sold 10 million shares in Oxford Nanopore, raising £21m. It retains a 7.23% stake valued at £151.5m. The sale enhances IP Group's financial flexibility while maintaining exposure to Oxford Nanopore's growth.
1 min readOxford Nanopore Technologies' stock rose 7.3% to 214p, hitting a 52-week high of 218.4p. Deutsche Bank raised its price target to 210 GBp, and Panmure Liberum upgraded the stock to Buy. A court injunction against MGI Tech and insider share purchases also supported the rally. The FTSE 250 index advanced 0.9%, aiding the stock's performance.
2 min readAECOM won a contract from the Santa Clara Valley Water District to design a water reuse facility in California. The project will test direct potable reuse for future drinking water. Tetra Tech secured a $17M EPA contract, EA Engineering won broadband roles, and Worley landed BHP and Ontario energy storage work.
1 min readOnterris Inc. (NYSE:ONT) reported Q2 revenue of $186.7M, down from $234.5M YoY, and cut 2026 guidance. EBITDA margin improved to 17.1%. The company initiated a strategic review and adopted a poison pill. Net income fell to $1.4M, and operating cash flow turned negative. Hedge fund ownership declined, while short interest rose to 10.22%.
2 min readOxford Nanopore Technologies' shares fell 6.5% to 162.08p after Novo Holdings sold 49 million shares at a 12.3% discount. This follows mixed reactions to the company's H1 2026 results, showing revenue growth but geographic weaknesses. The UK's FTSE 100 also declined due to Middle East tensions and rising bond yields, impacting growth stocks like Oxford Nanopore.
2 min readMerck (MRK) and Moderna (MRNA) announced positive Phase III results for their cancer vaccine, intismeran, showing improved outcomes when combined with Keytruda. Shares of both companies surged, with Moderna gaining 130.5% over three days. Sequencing companies like Illumina (ILMN) and PacBio (PACB) also saw gains due to the personalized nature of the therapy. Analysts upgraded Moderna's stock, citing broadened sales potential, while others remained cautious about long-term expectations.
3 min readOxford Nanopore Technologies' stock rose 6.6% after its interim results showed improved profitability, with gross margin expanding to 62.2% and adjusted EBITDA losses halving. The company also announced a new licensing deal expected to generate $20 million in fees. Berenberg maintained a Buy rating but lowered its price target to £2.00. The stock is still below its 52-week high of 215.6p.
2 min readOnterris (NYSE: ONT) said it won more than $9 million in new project awards in the first half of 2026 from a long-standing global integrated energy client. The awards follow a multi-million-dollar five-year global contract awarded in 2025 for assessment, remediation and reclamation. Onterris cites a 20+ year partnership and expanded services across regions.
3 min readAnalysts’ views are mixed on industrial stocks VSE (VSEC) and Onterris (ONT). Truist’s Alexandra Mandery kept a Buy on VSE; consensus is Strong Buy with an average $259 target. For Onterris, Evercore ISI’s Durgesh Chopra downgraded to Hold with a $13 target; Barclays also downgraded to Hold at $15.
3 min readBank of America downgraded Onterris, Inc. to Underperform from Neutral and cut its price target to $18 from $31, according to the note cited in the article. The stock is shown trading around $15.24 at the time of publication, with the article referencing Onterris’ recent earnings call.
1 min read
